Time from Diagnosis to Treatment Does Not Affect Outcome in Intensively Treated Patients with Newly Diagnosed Acute Myeloid Leukemia
Christoph Röllig(University Hospital Carl Gustav Carus), Martin Bornhäuser(Technische Universität Dresden), Michael Krämer(University Hospital Carl Gustav Carus), Frank Heits(Agaplesion Diakonieklinikum Rotenburg), Hermann Einsele(Universitätsklinikum Würzburg), Gerhard Ehninger(University Hospital Carl Gustav Carus), Norbert Frickhofen(Helios Dr. Horst Schmidt Kliniken Wiesbaden), Markus Schaich(Rems-Murr-Klinikum), Sebastian Scholl(Jena University Hospital), Alexander Kiani(Bayreuth Medical Center), Björn Steffen(Goethe University Frankfurt), Carsten Müller‐Tidow(Heidelberg University), Claudia D. Baldus(University Hospital Schleswig-Holstein), Andreas Hochhaus(Jena University Hospital), Jan Moritz Middeke(Fresenius (Germany)), Dirk Niemann(Gemeinschaftsklinikum Mittelrhein), Tim H. Brümmendorf(National University Cancer Institute, Singapore), Johannes Kullmer(DIAKO), Andreas Neubauer(RWTH Aachen University), Edgar Jost(Universitätsklinikum Aachen), Regina Herbst(Klinikum Chemnitz), Mathias Hänel(Klinikum Chemnitz), Ulrich Krümpelmann(Klinikum Bielefeld), Lars Fransecky, Volker Kunzmann(University of Würzburg), Christoph Schliemann(University Hospital Münster), Ulrich Kaiser(University of Applied Sciences Landshut), Uwe Platzbecker(National Center for Tumor Diseases), Friedrich Stoelzel(University Hospital Carl Gustav Carus), Stefan W. Krause(Universitätsklinikum Erlangen), Richard Noppeney(Essen University Hospital), Maxi Wass(University Hospital in Halle), Hubert Serve(Goethe University Frankfurt), Tim Sauer(Heidelberg University), Stefan Klein(Praxis für Hämatologie und Onkologie), Martin Kaufmann(Robert Bosch Hospital), Malte von Bonin(Städtisches Klinikum Dresden), Jan-Henrik Mikesch(University Hospital Münster), Kerstin Schäfer‐Eckart(Nuremberg Hospital), Johannes Schetelig(University Hospital Carl Gustav Carus), Alwin Krämer(Heidelberg University), Christian Thiede(University Hospital Carl Gustav Carus)
Cited by 18
Related Papers
The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms
|Leukemia|2022|3.8k
Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN
|Blood|2022|3.1k
Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a <i>FLT3</i> Mutation
|New England Journal of Medicine|2017|2.2k
FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer (FIRE-3): a randomised, open-label, phase 3 trial
|The Lancet Oncology|2014|1.7k
Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia
|New England Journal of Medicine|2013|1.6k